Latest Insider Transactions at Silk Road Medical Inc (SILK)
This section provides a real-time view of insider transactions for Silk Road Medical Inc (SILK). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Silk Road Medical Inc to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Silk Road Medical Inc's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 02
2021
|
Erica J. Rogers President and CEO |
SELL
Open market or private sale
|
Direct |
1,651
-0.61%
|
$92,456
$56.62 P/Share
|
|
Mar 01
2021
|
Erica J. Rogers President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,692
-1.27%
|
$94,752
$56.75 P/Share
|
|
Mar 01
2021
|
Erica J. Rogers President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
21,700
+14.0%
|
-
|
|
Mar 01
2021
|
Lucas W. Buchanan COO & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
893
-0.5%
|
$50,008
$56.86 P/Share
|
|
Mar 01
2021
|
Lucas W. Buchanan COO & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
11,300
+5.98%
|
-
|
|
Mar 01
2021
|
Richard Ruedy EVPClin&Reg.Affairs&QA |
SELL
Payment of exercise price or tax liability
|
Direct |
340
-0.26%
|
$19,380
$57.12 P/Share
|
|
Mar 01
2021
|
Richard Ruedy EVPClin&Reg.Affairs&QA |
BUY
Grant, award, or other acquisition
|
Direct |
4,300
+3.15%
|
-
|
|
Mar 01
2021
|
Andrew S. Davis Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
508
-1.57%
|
$28,448
$56.95 P/Share
|
|
Mar 01
2021
|
Andrew S. Davis Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,300
+26.65%
|
-
|
|
Mar 01
2021
|
Andrew S. Davis Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
7,472
-27.4%
|
$418,432
$56.49 P/Share
|
|
Mar 01
2021
|
Andrew S. Davis Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,472
+21.5%
|
$7,472
$1.46 P/Share
|
|
Feb 26
2021
|
Lucas W. Buchanan COO & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
917
-0.55%
|
$51,352
$56.63 P/Share
|
|
Feb 26
2021
|
Lucas W. Buchanan COO & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
2,676
+1.57%
|
-
|
|
Feb 26
2021
|
Richard Ruedy EVPClin&Reg.Affairs&QA |
BUY
Grant, award, or other acquisition
|
Direct |
1,047
+0.78%
|
-
|
|
Feb 26
2021
|
Richard Ruedy EVPClin&Reg.Affairs&QA |
SELL
Payment of exercise price or tax liability
|
Direct |
350
-0.27%
|
$19,600
$56.7 P/Share
|
|
Feb 26
2021
|
Andrew S. Davis Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,828
+5.34%
|
-
|
|
Feb 26
2021
|
Andrew S. Davis Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
522
-1.68%
|
$29,232
$56.59 P/Share
|
|
Feb 24
2021
|
Lucas W. Buchanan COO & CFO |
SELL
Open market or private sale
|
Direct |
10,000
-1.96%
|
$530,000
$53.64 P/Share
|
|
Feb 24
2021
|
Lucas W. Buchanan COO & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+1.89%
|
$80,000
$8.38 P/Share
|
|
Feb 17
2021
|
Lucas W. Buchanan COO & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+5.73%
|
$10,000
$1.6 P/Share
|
|
Feb 11
2021
|
Erica J. Rogers President and CEO |
SELL
Open market or private sale
|
Direct |
11,000
-8.97%
|
$649,000
$59.55 P/Share
|
|
Feb 11
2021
|
Erica J. Rogers President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
11,000
+8.23%
|
$11,000
$1.6 P/Share
|
|
Feb 01
2021
|
Andrew S. Davis Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
7,472
-27.4%
|
$403,488
$54.12 P/Share
|
|
Feb 01
2021
|
Andrew S. Davis Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,472
+21.5%
|
$7,472
$1.46 P/Share
|
|
Jan 27
2021
|
Lucas W. Buchanan COO & CFO |
SELL
Open market or private sale
|
Direct |
10,000
-6.08%
|
$540,000
$54.86 P/Share
|
|
Jan 27
2021
|
Lucas W. Buchanan COO & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+5.73%
|
$40,000
$4.73 P/Share
|
|
Jan 11
2021
|
Erica J. Rogers President and CEO |
SELL
Open market or private sale
|
Direct |
11,000
-8.97%
|
$649,000
$59.66 P/Share
|
|
Jan 11
2021
|
Erica J. Rogers President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
11,000
+8.23%
|
$11,000
$1.6 P/Share
|
|
Jan 04
2021
|
Andrew S. Davis Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
7,472
-27.4%
|
$440,848
$59.67 P/Share
|
|
Jan 04
2021
|
Andrew S. Davis Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,472
+21.5%
|
$7,472
$1.46 P/Share
|
|
Dec 29
2020
|
Lucas W. Buchanan COO & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
18,000
+5.46%
|
$54,000
$3.17 P/Share
|
|
Dec 29
2020
|
Lucas W. Buchanan COO & CFO |
SELL
Open market or private sale
|
Direct |
10,000
-6.39%
|
$600,000
$60.04 P/Share
|
|
Dec 14
2020
|
Lucas W. Buchanan COO & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
7,000
+4.56%
|
$7,000
$1.6 P/Share
|
|
Dec 11
2020
|
Erica J. Rogers President and CEO |
SELL
Open market or private sale
|
Direct |
11,000
-4.63%
|
$638,000
$58.35 P/Share
|
|
Dec 11
2020
|
Erica J. Rogers President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
11,000
+4.37%
|
$11,000
$1.53 P/Share
|
|
Dec 11
2020
|
Lucas W. Buchanan COO & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
7,000
+4.77%
|
$7,000
$1.6 P/Share
|
|
Dec 01
2020
|
Andrew S. Davis Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
7,472
-27.4%
|
$418,432
$56.63 P/Share
|
|
Dec 01
2020
|
Andrew S. Davis Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,472
+21.5%
|
$7,472
$1.46 P/Share
|
|
Nov 25
2020
|
Lucas W. Buchanan COO & CFO |
SELL
Open market or private sale
|
Direct |
10,000
-7.02%
|
$570,000
$57.08 P/Share
|
|
Nov 25
2020
|
Lucas W. Buchanan COO & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+6.56%
|
$40,000
$4.73 P/Share
|
|
Nov 23
2020
|
Richard Ruedy EVPClin&Reg.Affairs&QA |
BUY
Exercise of conversion of derivative security
|
Direct |
108,974
+29.69%
|
$108,974
$1.55 P/Share
|
|
Nov 20
2020
|
Lucas W. Buchanan COO & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
83
+0.06%
|
$2,739
$33.06 P/Share
|
|
Nov 17
2020
|
Richard Ruedy EVPClin&Reg.Affairs&QA |
SELL
Open market or private sale
|
Direct |
14,221
-27.07%
|
$839,039
$59.84 P/Share
|
|
Nov 17
2020
|
Richard Ruedy EVPClin&Reg.Affairs&QA |
BUY
Exercise of conversion of derivative security
|
Direct |
14,221
+21.3%
|
$14,221
$1.42 P/Share
|
|
Nov 11
2020
|
Erica J. Rogers President and CEO |
SELL
Open market or private sale
|
Direct |
11,000
-8.97%
|
$693,000
$63.44 P/Share
|
|
Nov 11
2020
|
Erica J. Rogers President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
11,000
+8.23%
|
$11,000
$1.46 P/Share
|
|
Nov 06
2020
|
Lucas W. Buchanan COO & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
21,496
+13.96%
|
-
|
|
Nov 02
2020
|
Andrew S. Davis Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
6,640
-25.11%
|
$405,040
$61.37 P/Share
|
|
Nov 02
2020
|
Andrew S. Davis Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,640
+20.07%
|
$6,640
$1.46 P/Share
|
|
Oct 14
2020
|
Lucas W. Buchanan COO & CFO |
SELL
Open market or private sale
|
Direct |
9,600
-4.11%
|
$624,000
$65.21 P/Share
|